174 related articles for article (PubMed ID: 22546640)
1. Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations.
Sato D; Kurita M; Ozaki M; Kaji N; Takushima A; Harii K
Eur J Vasc Endovasc Surg; 2012 Jul; 44(1):73-6. PubMed ID: 22546640
[TBL] [Abstract][Full Text] [Related]
2. Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study.
Fujiki M; Kurita M; Ozaki M; Kawakami H; Kaji N; Takushima A; Harii K
J Plast Surg Hand Surg; 2012 Sep; 46(3-4):145-51. PubMed ID: 22686430
[TBL] [Abstract][Full Text] [Related]
3. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
Jain R; Bandhu S; Sawhney S; Mittal R
J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
[TBL] [Abstract][Full Text] [Related]
4. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy.
Hyodoh H; Fujita A; Hyodoh K; Furuse M; Kamisawa O; Hareyama M
Cardiovasc Intervent Radiol; 2001; 24(5):348-51. PubMed ID: 11815844
[TBL] [Abstract][Full Text] [Related]
5. Is endoscopic paravascular injection of sclerosing agents reasonable in the control of GI bleeding?
Tatemichi M; Nagata H; Sekizuka E; Morishita T; Mizuki A; Ishii H
Gastrointest Endosc; 1999 Oct; 50(4):499-505. PubMed ID: 10502170
[TBL] [Abstract][Full Text] [Related]
6. Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
Tatemichi M; Nagata H; Sekizuka E; Morishita T; Miyairi M; Tsuchiya M; Ishii H
Dig Dis Sci; 1996 Mar; 41(3):562-70. PubMed ID: 8617137
[TBL] [Abstract][Full Text] [Related]
7. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
8. Arteriovenous malformations: ethanolamine oleate sclerotherapy.
Hyodoh H; Hyodoh K
Acta Chir Iugosl; 2007; 54(3):81-6. PubMed ID: 17988037
[TBL] [Abstract][Full Text] [Related]
9. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
Lee CH; Chen SG
Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the effect of injected ethanol on pulmonary arterial pressure during sclerotherapy of arteriovenous malformations: relationship with dose of ethanol.
Ko JS; Kim JA; Do YS; Kwon MA; Choi SJ; Gwak MS; Lee JJ; Yang M
J Vasc Interv Radiol; 2009 Jan; 20(1):39-45; quiz 45. PubMed ID: 19028113
[TBL] [Abstract][Full Text] [Related]
11. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
Liu Y; Liu D; Wang Y; Zhang W; Zhao F
J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
[TBL] [Abstract][Full Text] [Related]
12. Changes in pulmonary artery pressures during ethanol sclerotherapy for arteriovenous malformations: identifying the most vulnerable period.
Ko JS; Kim CS; Shin BS; Kim MJ; Lee JH; Kim KH; Do YS
Clin Radiol; 2011 Jul; 66(7):639-44. PubMed ID: 21513926
[TBL] [Abstract][Full Text] [Related]
13. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.
Johann AC; Aguiar MC; do Carmo MA; Gomez RS; Castro WH; Mesquita RA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Nov; 100(5):579-84. PubMed ID: 16243243
[TBL] [Abstract][Full Text] [Related]
15. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation.
Marrocco-Trischitta MM; Guerrini P; Abeni D; Stillo F
Dermatol Surg; 2002 Feb; 28(2):153-5. PubMed ID: 11860427
[TBL] [Abstract][Full Text] [Related]
16. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy of maxillofacial venous malformations.
Wei ZJ
J Oral Maxillofac Surg; 2010 Jun; 68(6):1456-7; author reply 1457. PubMed ID: 20493387
[No Abstract] [Full Text] [Related]
18. [Abnormal effect of absolute ethanol sclerotherapy for arteriovenous malformations on hemodynamics].
Jiang J; Huang Y; Xu H; Jiang H
Shanghai Kou Qiang Yi Xue; 2014 Jun; 23(3):346-9. PubMed ID: 25102881
[TBL] [Abstract][Full Text] [Related]
19. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy.
Smithers CJ; Vogel AM; Kozakewich HP; Freedman DA; Burrows PE; Fauza DO; Fishman SJ
J Pediatr Surg; 2005 Jun; 40(6):920-5. PubMed ID: 15991171
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck.
Deveikis JP
Arch Facial Plast Surg; 2005; 7(5):322-5. PubMed ID: 16172342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
